Global Hydroxyprogesterone Caproate Injection Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hydroxyprogesterone Caproate Injection market size is predicted to grow from US$ 265 million in 2025 to US$ 291 million in 2031; it is expected to grow at a CAGR of 1.6% from 2025 to 2031.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
LP Information, Inc. (LPI) ' newest research report, the “Hydroxyprogesterone Caproate Injection Industry Forecast” looks at past sales and reviews total world Hydroxyprogesterone Caproate Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Hydroxyprogesterone Caproate Injection sales for 2025 through 2031. With Hydroxyprogesterone Caproate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydroxyprogesterone Caproate Injection industry.
This Insight Report provides a comprehensive analysis of the global Hydroxyprogesterone Caproate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hydroxyprogesterone Caproate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hydroxyprogesterone Caproate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydroxyprogesterone Caproate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydroxyprogesterone Caproate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxyprogesterone Caproate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hydroxyprogesterone Caproate Injection market?
What factors are driving Hydroxyprogesterone Caproate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hydroxyprogesterone Caproate Injection market opportunities vary by end market size?
How does Hydroxyprogesterone Caproate Injection break out by Type, by Application?
The global Hydroxyprogesterone Caproate Injection market size is predicted to grow from US$ 265 million in 2025 to US$ 291 million in 2031; it is expected to grow at a CAGR of 1.6% from 2025 to 2031.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
LP Information, Inc. (LPI) ' newest research report, the “Hydroxyprogesterone Caproate Injection Industry Forecast” looks at past sales and reviews total world Hydroxyprogesterone Caproate Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Hydroxyprogesterone Caproate Injection sales for 2025 through 2031. With Hydroxyprogesterone Caproate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hydroxyprogesterone Caproate Injection industry.
This Insight Report provides a comprehensive analysis of the global Hydroxyprogesterone Caproate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hydroxyprogesterone Caproate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hydroxyprogesterone Caproate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hydroxyprogesterone Caproate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hydroxyprogesterone Caproate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Hydroxyprogesterone Caproate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1 mL Injection(Including 1.1 mL)
- 5 mL Injection
- Hospitals Injection
- Clinics Injection
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AMAG Pharmaceuticals
- Mcguff Pharmaceuticals Inc
- Aspen Oss B.V
- American Regent, Inc.
- Mylan Institutional
What is the 10-year outlook for the global Hydroxyprogesterone Caproate Injection market?
What factors are driving Hydroxyprogesterone Caproate Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hydroxyprogesterone Caproate Injection market opportunities vary by end market size?
How does Hydroxyprogesterone Caproate Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hydroxyprogesterone Caproate Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hydroxyprogesterone Caproate Injection by Country/Region, 2020, 2024 & 2031
2.2 Hydroxyprogesterone Caproate Injection Segment by Type
2.2.1 1 mL Injection(Including 1.1 mL)
2.2.2 5 mL Injection
2.3 Hydroxyprogesterone Caproate Injection Sales by Type
2.3.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Type (2020-2025)
2.4 Hydroxyprogesterone Caproate Injection Segment by Application
2.4.1 Hospitals Injection
2.4.2 Clinics Injection
2.5 Hydroxyprogesterone Caproate Injection Sales by Application
2.5.1 Global Hydroxyprogesterone Caproate Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hydroxyprogesterone Caproate Injection Breakdown Data by Company
3.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Company (2020-2025)
3.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2020-2025)
3.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Company (2020-2025)
3.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company (2020-2025)
3.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Company
3.4 Key Manufacturers Hydroxyprogesterone Caproate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hydroxyprogesterone Caproate Injection Product Location Distribution
3.4.2 Players Hydroxyprogesterone Caproate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HYDROXYPROGESTERONE CAPROATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Hydroxyprogesterone Caproate Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hydroxyprogesterone Caproate Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hydroxyprogesterone Caproate Injection Sales Growth
4.4 APAC Hydroxyprogesterone Caproate Injection Sales Growth
4.5 Europe Hydroxyprogesterone Caproate Injection Sales Growth
4.6 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Growth
5 AMERICAS
5.1 Americas Hydroxyprogesterone Caproate Injection Sales by Country
5.1.1 Americas Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
5.1.2 Americas Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
5.2 Americas Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
5.3 Americas Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hydroxyprogesterone Caproate Injection Sales by Region
6.1.1 APAC Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025)
6.1.2 APAC Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025)
6.2 APAC Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
6.3 APAC Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hydroxyprogesterone Caproate Injection by Country
7.1.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
7.1.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
7.2 Europe Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
7.3 Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hydroxyprogesterone Caproate Injection by Country
8.1.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hydroxyprogesterone Caproate Injection
10.3 Manufacturing Process Analysis of Hydroxyprogesterone Caproate Injection
10.4 Industry Chain Structure of Hydroxyprogesterone Caproate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hydroxyprogesterone Caproate Injection Distributors
11.3 Hydroxyprogesterone Caproate Injection Customer
12 WORLD FORECAST REVIEW FOR HYDROXYPROGESTERONE CAPROATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Hydroxyprogesterone Caproate Injection Market Size Forecast by Region
12.1.1 Global Hydroxyprogesterone Caproate Injection Forecast by Region (2026-2031)
12.1.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hydroxyprogesterone Caproate Injection Forecast by Type (2026-2031)
12.7 Global Hydroxyprogesterone Caproate Injection Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AMAG Pharmaceuticals
13.1.1 AMAG Pharmaceuticals Company Information
13.1.2 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AMAG Pharmaceuticals Main Business Overview
13.1.5 AMAG Pharmaceuticals Latest Developments
13.2 Mcguff Pharmaceuticals Inc
13.2.1 Mcguff Pharmaceuticals Inc Company Information
13.2.2 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mcguff Pharmaceuticals Inc Main Business Overview
13.2.5 Mcguff Pharmaceuticals Inc Latest Developments
13.3 Aspen Oss B.V
13.3.1 Aspen Oss B.V Company Information
13.3.2 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aspen Oss B.V Main Business Overview
13.3.5 Aspen Oss B.V Latest Developments
13.4 American Regent, Inc.
13.4.1 American Regent, Inc. Company Information
13.4.2 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 American Regent, Inc. Main Business Overview
13.4.5 American Regent, Inc. Latest Developments
13.5 Mylan Institutional
13.5.1 Mylan Institutional Company Information
13.5.2 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Institutional Main Business Overview
13.5.5 Mylan Institutional Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Hydroxyprogesterone Caproate Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hydroxyprogesterone Caproate Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 1 mL Injection(Including 1.1 mL)
Table 4. Major Players of 5 mL Injection
Table 5. Global Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 6. Global Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Table 7. Global Hydroxyprogesterone Caproate Injection Revenue byType (2020-2025) & ($ million)
Table 8. Global Hydroxyprogesterone Caproate Injection Revenue Market Share byType (2020-2025)
Table 9. Global Hydroxyprogesterone Caproate Injection Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Hydroxyprogesterone Caproate Injection Sale by Application (2020-2025) & (K Units)
Table 11. Global Hydroxyprogesterone Caproate Injection Sale Market Share by Application (2020-2025)
Table 12. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Hydroxyprogesterone Caproate Injection Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Hydroxyprogesterone Caproate Injection Sales by Company (2020-2025) & (K Units)
Table 16. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2020-2025)
Table 17. Global Hydroxyprogesterone Caproate Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Hydroxyprogesterone Caproate Injection Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Hydroxyprogesterone Caproate Injection Producing Area Distribution and Sales Area
Table 21. Players Hydroxyprogesterone Caproate Injection Products Offered
Table 22. Hydroxyprogesterone Caproate Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Hydroxyprogesterone Caproate Injection Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Hydroxyprogesterone Caproate Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Hydroxyprogesterone Caproate Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Hydroxyprogesterone Caproate Injection Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Hydroxyprogesterone Caproate Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 34. Americas Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 37. Americas Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 38. APAC Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
Table 39. APAC Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 42. APAC Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 43. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 44. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 46. Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Hydroxyprogesterone Caproate Injection
Table 52. Key Market Challenges & Risks of Hydroxyprogesterone Caproate Injection
Table 53. Key IndustryTrends of Hydroxyprogesterone Caproate Injection
Table 54. Hydroxyprogesterone Caproate Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Hydroxyprogesterone Caproate Injection Distributors List
Table 57. Hydroxyprogesterone Caproate Injection Customer List
Table 58. Global Hydroxyprogesterone Caproate Injection SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Hydroxyprogesterone Caproate Injection RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Hydroxyprogesterone Caproate Injection SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Hydroxyprogesterone Caproate Injection Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Hydroxyprogesterone Caproate Injection SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Hydroxyprogesterone Caproate Injection Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Hydroxyprogesterone Caproate Injection SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Hydroxyprogesterone Caproate Injection RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Hydroxyprogesterone Caproate Injection SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Hydroxyprogesterone Caproate Injection RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Hydroxyprogesterone Caproate Injection SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Hydroxyprogesterone Caproate Injection RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Hydroxyprogesterone Caproate Injection SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Hydroxyprogesterone Caproate Injection RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. AMAG Pharmaceuticals Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 74. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. AMAG Pharmaceuticals Main Business
Table 76. AMAG Pharmaceuticals Latest Developments
Table 77. Mcguff Pharmaceuticals Inc Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 79. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Mcguff Pharmaceuticals Inc Main Business
Table 81. Mcguff Pharmaceuticals Inc Latest Developments
Table 82. Aspen Oss B.V Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 84. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Aspen Oss B.V Main Business
Table 86. Aspen Oss B.V Latest Developments
Table 87. American Regent, Inc. Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 89. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. American Regent, Inc. Main Business
Table 91. American Regent, Inc. Latest Developments
Table 92. Mylan Institutional Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 94. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Mylan Institutional Main Business
Table 96. Mylan Institutional Latest Developments
LIST OFFIGURES
Figure 1. Picture of Hydroxyprogesterone Caproate Injection
Figure 2. Hydroxyprogesterone Caproate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hydroxyprogesterone Caproate Injection Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hydroxyprogesterone Caproate Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hydroxyprogesterone Caproate Injection Sales Market Share by Country/Region (2024)
Figure 10. Hydroxyprogesterone Caproate Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 1 mL Injection(Including 1.1 mL)
Figure 12. Product Picture of 5 mL Injection
Figure 13. Global Hydroxyprogesterone Caproate Injection Sales Market Share byType in 2025
Figure 14. Global Hydroxyprogesterone Caproate Injection Revenue Market Share byType (2020-2025)
Figure 15. Hydroxyprogesterone Caproate Injection Consumed in Hospitals Injection
Figure 16. Global Hydroxyprogesterone Caproate Injection Market: Hospitals Injection (2020-2025) & (K Units)
Figure 17. Hydroxyprogesterone Caproate Injection Consumed in Clinics Injection
Figure 18. Global Hydroxyprogesterone Caproate Injection Market: Clinics Injection (2020-2025) & (K Units)
Figure 19. Global Hydroxyprogesterone Caproate Injection Sale Market Share by Application (2024)
Figure 20. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application in 2025
Figure 21. Hydroxyprogesterone Caproate Injection Sales by Company in 2025 (K Units)
Figure 22. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Company in 2025
Figure 23. Hydroxyprogesterone Caproate Injection Revenue by Company in 2025 ($ millions)
Figure 24. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company in 2025
Figure 25. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 28. Americas Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 29. APAC Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 30. APAC Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 31. Europe Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 32. Europe Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 35. Americas Hydroxyprogesterone Caproate Injection Sales Market Share by Country in 2025
Figure 36. Americas Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2025)
Figure 37. Americas Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 38. Americas Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 39. United States Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Hydroxyprogesterone Caproate Injection Sales Market Share by Region in 2025
Figure 44. APAC Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2025)
Figure 45. APAC Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 46. APAC Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 47. China Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. India Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country in 2025
Figure 55. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2025)
Figure 56. Europe Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 57. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 58. Germany Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 59.France Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 66. Egypt Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Hydroxyprogesterone Caproate Injection in 2025
Figure 72. Manufacturing Process Analysis of Hydroxyprogesterone Caproate Injection
Figure 73. Industry Chain Structure of Hydroxyprogesterone Caproate Injection
Figure 74. Channels of Distribution
Figure 75. Global Hydroxyprogesterone Caproate Injection Sales MarketForecast by Region (2026-2031)
Figure 76. Global Hydroxyprogesterone Caproate Injection Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Hydroxyprogesterone Caproate Injection Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Hydroxyprogesterone Caproate Injection Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Hydroxyprogesterone Caproate Injection Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Hydroxyprogesterone Caproate Injection Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hydroxyprogesterone Caproate Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hydroxyprogesterone Caproate Injection by Country/Region, 2020, 2024 & 2031
2.2 Hydroxyprogesterone Caproate Injection Segment by Type
2.2.1 1 mL Injection(Including 1.1 mL)
2.2.2 5 mL Injection
2.3 Hydroxyprogesterone Caproate Injection Sales by Type
2.3.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Type (2020-2025)
2.4 Hydroxyprogesterone Caproate Injection Segment by Application
2.4.1 Hospitals Injection
2.4.2 Clinics Injection
2.5 Hydroxyprogesterone Caproate Injection Sales by Application
2.5.1 Global Hydroxyprogesterone Caproate Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Hydroxyprogesterone Caproate Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hydroxyprogesterone Caproate Injection Breakdown Data by Company
3.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Company (2020-2025)
3.1.2 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2020-2025)
3.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Company (2020-2025)
3.2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company (2020-2025)
3.3 Global Hydroxyprogesterone Caproate Injection Sale Price by Company
3.4 Key Manufacturers Hydroxyprogesterone Caproate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hydroxyprogesterone Caproate Injection Product Location Distribution
3.4.2 Players Hydroxyprogesterone Caproate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HYDROXYPROGESTERONE CAPROATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Hydroxyprogesterone Caproate Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hydroxyprogesterone Caproate Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Hydroxyprogesterone Caproate Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hydroxyprogesterone Caproate Injection Sales Growth
4.4 APAC Hydroxyprogesterone Caproate Injection Sales Growth
4.5 Europe Hydroxyprogesterone Caproate Injection Sales Growth
4.6 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Growth
5 AMERICAS
5.1 Americas Hydroxyprogesterone Caproate Injection Sales by Country
5.1.1 Americas Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
5.1.2 Americas Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
5.2 Americas Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
5.3 Americas Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hydroxyprogesterone Caproate Injection Sales by Region
6.1.1 APAC Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025)
6.1.2 APAC Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025)
6.2 APAC Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
6.3 APAC Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hydroxyprogesterone Caproate Injection by Country
7.1.1 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
7.1.2 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
7.2 Europe Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
7.3 Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hydroxyprogesterone Caproate Injection by Country
8.1.1 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hydroxyprogesterone Caproate Injection
10.3 Manufacturing Process Analysis of Hydroxyprogesterone Caproate Injection
10.4 Industry Chain Structure of Hydroxyprogesterone Caproate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hydroxyprogesterone Caproate Injection Distributors
11.3 Hydroxyprogesterone Caproate Injection Customer
12 WORLD FORECAST REVIEW FOR HYDROXYPROGESTERONE CAPROATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Hydroxyprogesterone Caproate Injection Market Size Forecast by Region
12.1.1 Global Hydroxyprogesterone Caproate Injection Forecast by Region (2026-2031)
12.1.2 Global Hydroxyprogesterone Caproate Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hydroxyprogesterone Caproate Injection Forecast by Type (2026-2031)
12.7 Global Hydroxyprogesterone Caproate Injection Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AMAG Pharmaceuticals
13.1.1 AMAG Pharmaceuticals Company Information
13.1.2 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AMAG Pharmaceuticals Main Business Overview
13.1.5 AMAG Pharmaceuticals Latest Developments
13.2 Mcguff Pharmaceuticals Inc
13.2.1 Mcguff Pharmaceuticals Inc Company Information
13.2.2 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mcguff Pharmaceuticals Inc Main Business Overview
13.2.5 Mcguff Pharmaceuticals Inc Latest Developments
13.3 Aspen Oss B.V
13.3.1 Aspen Oss B.V Company Information
13.3.2 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aspen Oss B.V Main Business Overview
13.3.5 Aspen Oss B.V Latest Developments
13.4 American Regent, Inc.
13.4.1 American Regent, Inc. Company Information
13.4.2 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 American Regent, Inc. Main Business Overview
13.4.5 American Regent, Inc. Latest Developments
13.5 Mylan Institutional
13.5.1 Mylan Institutional Company Information
13.5.2 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
13.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Mylan Institutional Main Business Overview
13.5.5 Mylan Institutional Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Hydroxyprogesterone Caproate Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hydroxyprogesterone Caproate Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 1 mL Injection(Including 1.1 mL)
Table 4. Major Players of 5 mL Injection
Table 5. Global Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 6. Global Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Table 7. Global Hydroxyprogesterone Caproate Injection Revenue byType (2020-2025) & ($ million)
Table 8. Global Hydroxyprogesterone Caproate Injection Revenue Market Share byType (2020-2025)
Table 9. Global Hydroxyprogesterone Caproate Injection Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Hydroxyprogesterone Caproate Injection Sale by Application (2020-2025) & (K Units)
Table 11. Global Hydroxyprogesterone Caproate Injection Sale Market Share by Application (2020-2025)
Table 12. Global Hydroxyprogesterone Caproate Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Hydroxyprogesterone Caproate Injection Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Hydroxyprogesterone Caproate Injection Sales by Company (2020-2025) & (K Units)
Table 16. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Company (2020-2025)
Table 17. Global Hydroxyprogesterone Caproate Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Hydroxyprogesterone Caproate Injection Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Hydroxyprogesterone Caproate Injection Producing Area Distribution and Sales Area
Table 21. Players Hydroxyprogesterone Caproate Injection Products Offered
Table 22. Hydroxyprogesterone Caproate Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Hydroxyprogesterone Caproate Injection Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Hydroxyprogesterone Caproate Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Hydroxyprogesterone Caproate Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Hydroxyprogesterone Caproate Injection Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Hydroxyprogesterone Caproate Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 34. Americas Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 37. Americas Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 38. APAC Hydroxyprogesterone Caproate Injection Sales by Region (2020-2025) & (K Units)
Table 39. APAC Hydroxyprogesterone Caproate Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Hydroxyprogesterone Caproate Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 42. APAC Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 43. Europe Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 44. Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 46. Europe Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Hydroxyprogesterone Caproate Injection
Table 52. Key Market Challenges & Risks of Hydroxyprogesterone Caproate Injection
Table 53. Key IndustryTrends of Hydroxyprogesterone Caproate Injection
Table 54. Hydroxyprogesterone Caproate Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Hydroxyprogesterone Caproate Injection Distributors List
Table 57. Hydroxyprogesterone Caproate Injection Customer List
Table 58. Global Hydroxyprogesterone Caproate Injection SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Hydroxyprogesterone Caproate Injection RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Hydroxyprogesterone Caproate Injection SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Hydroxyprogesterone Caproate Injection Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Hydroxyprogesterone Caproate Injection SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Hydroxyprogesterone Caproate Injection Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Hydroxyprogesterone Caproate Injection SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Hydroxyprogesterone Caproate Injection RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Hydroxyprogesterone Caproate Injection SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Hydroxyprogesterone Caproate Injection RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Hydroxyprogesterone Caproate Injection SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Hydroxyprogesterone Caproate Injection RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Hydroxyprogesterone Caproate Injection SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Hydroxyprogesterone Caproate Injection RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. AMAG Pharmaceuticals Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 74. AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. AMAG Pharmaceuticals Main Business
Table 76. AMAG Pharmaceuticals Latest Developments
Table 77. Mcguff Pharmaceuticals Inc Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 79. Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Mcguff Pharmaceuticals Inc Main Business
Table 81. Mcguff Pharmaceuticals Inc Latest Developments
Table 82. Aspen Oss B.V Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 84. Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Aspen Oss B.V Main Business
Table 86. Aspen Oss B.V Latest Developments
Table 87. American Regent, Inc. Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 89. American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. American Regent, Inc. Main Business
Table 91. American Regent, Inc. Latest Developments
Table 92. Mylan Institutional Basic Information, Hydroxyprogesterone Caproate Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolios and Specifications
Table 94. Mylan Institutional Hydroxyprogesterone Caproate Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Mylan Institutional Main Business
Table 96. Mylan Institutional Latest Developments
LIST OFFIGURES
Figure 1. Picture of Hydroxyprogesterone Caproate Injection
Figure 2. Hydroxyprogesterone Caproate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hydroxyprogesterone Caproate Injection Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Hydroxyprogesterone Caproate Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hydroxyprogesterone Caproate Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hydroxyprogesterone Caproate Injection Sales Market Share by Country/Region (2024)
Figure 10. Hydroxyprogesterone Caproate Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 1 mL Injection(Including 1.1 mL)
Figure 12. Product Picture of 5 mL Injection
Figure 13. Global Hydroxyprogesterone Caproate Injection Sales Market Share byType in 2025
Figure 14. Global Hydroxyprogesterone Caproate Injection Revenue Market Share byType (2020-2025)
Figure 15. Hydroxyprogesterone Caproate Injection Consumed in Hospitals Injection
Figure 16. Global Hydroxyprogesterone Caproate Injection Market: Hospitals Injection (2020-2025) & (K Units)
Figure 17. Hydroxyprogesterone Caproate Injection Consumed in Clinics Injection
Figure 18. Global Hydroxyprogesterone Caproate Injection Market: Clinics Injection (2020-2025) & (K Units)
Figure 19. Global Hydroxyprogesterone Caproate Injection Sale Market Share by Application (2024)
Figure 20. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application in 2025
Figure 21. Hydroxyprogesterone Caproate Injection Sales by Company in 2025 (K Units)
Figure 22. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Company in 2025
Figure 23. Hydroxyprogesterone Caproate Injection Revenue by Company in 2025 ($ millions)
Figure 24. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Company in 2025
Figure 25. Global Hydroxyprogesterone Caproate Injection Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 28. Americas Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 29. APAC Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 30. APAC Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 31. Europe Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 32. Europe Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Hydroxyprogesterone Caproate Injection Revenue 2020-2025 ($ millions)
Figure 35. Americas Hydroxyprogesterone Caproate Injection Sales Market Share by Country in 2025
Figure 36. Americas Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2025)
Figure 37. Americas Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 38. Americas Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 39. United States Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Hydroxyprogesterone Caproate Injection Sales Market Share by Region in 2025
Figure 44. APAC Hydroxyprogesterone Caproate Injection Revenue Market Share by Region (2020-2025)
Figure 45. APAC Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 46. APAC Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 47. China Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. India Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Country in 2025
Figure 55. Europe Hydroxyprogesterone Caproate Injection Revenue Market Share by Country (2020-2025)
Figure 56. Europe Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 57. Europe Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 58. Germany Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 59.France Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2020-2025)
Figure 66. Egypt Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Hydroxyprogesterone Caproate Injection Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Hydroxyprogesterone Caproate Injection in 2025
Figure 72. Manufacturing Process Analysis of Hydroxyprogesterone Caproate Injection
Figure 73. Industry Chain Structure of Hydroxyprogesterone Caproate Injection
Figure 74. Channels of Distribution
Figure 75. Global Hydroxyprogesterone Caproate Injection Sales MarketForecast by Region (2026-2031)
Figure 76. Global Hydroxyprogesterone Caproate Injection Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Hydroxyprogesterone Caproate Injection Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Hydroxyprogesterone Caproate Injection Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Hydroxyprogesterone Caproate Injection Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Hydroxyprogesterone Caproate Injection Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Ginseng Supplements Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
111 pages
